1-155611218-A-G
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1
The NM_018116.4(MSTO1):c.293A>G(p.Gln98Arg) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000357 in 1,605,292 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_018116.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MSTO1 | NM_018116.4 | c.293A>G | p.Gln98Arg | missense_variant, splice_region_variant | 4/14 | ENST00000245564.8 | |
LOC105371452 | XR_922171.2 | n.77-1326T>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MSTO1 | ENST00000245564.8 | c.293A>G | p.Gln98Arg | missense_variant, splice_region_variant | 4/14 | 1 | NM_018116.4 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.00180 AC: 262AN: 145724Hom.: 0 Cov.: 20
GnomAD3 exomes AF: 0.000474 AC: 110AN: 232256Hom.: 0 AF XY: 0.000348 AC XY: 44AN XY: 126462
GnomAD4 exome AF: 0.000212 AC: 310AN: 1459454Hom.: 1 Cov.: 29 AF XY: 0.000186 AC XY: 135AN XY: 726024
GnomAD4 genome ? AF: 0.00180 AC: 263AN: 145838Hom.: 0 Cov.: 20 AF XY: 0.00174 AC XY: 123AN XY: 70690
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2023 | MSTO1: PP2, BP4 - |
Benign, criteria provided, single submitter | clinical testing | Invitae | Jul 13, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at